Advanced search
Publication Cover
OncoImmunology Volume 3, 2014 - Issue 8
Submit an article Journal homepage
694
Views
4
CrossRef citations to date
0
Altmetric
Brief Report

Anti-p21 autoantibodies detected in colorectal cancer patients: A proof of concept study

Faraz BishehsariDivision of Gastroenterology; Northwestern University; Chicago, IL USA
,
Johannes S GachDivision of Infectious Diseases; University of California Irvine; Irvine, CA USA
,
Naomi AkagiDivision of Gastroenterology and Hepatology; University of Illinois at Chicago; Chicago, IL USA
,
Molly K WebberSchool of Medicine; University of Pittsburgh; Pittsburgh, PA USA
,
Jessica BauerDivision of Gastroenterology and Hepatology; University of Illinois at Chicago; Chicago, IL USA
&
Barbara H JungDivision of Gastroenterology and Hepatology; University of Illinois at Chicago; Chicago, IL USACorrespondence[email protected]
Article: e952202 | Received 10 May 2014, Accepted 04 Jun 2014, Published online: 30 Oct 2014

References

  • Jaras K, Anderson K. Autoantibodies in cancer: prognostic biomarkers and immune activation. Expert Rev Proteomics 2011; 8(5):577-89; PMID:21999829; http://dx.doi.org/10.1586/epr.11.48
  • Chen H, Werner S, Tao S, Zörnig I, Brenner H. Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer. Cancer Lett 2014; 346(2):178-87; PMID:24462820; http://dx.doi.org/10.1016/j.canlet.2014.01.007
  • Heo CK, Bahk YY, Cho EW. Tumor-associated autoantibodies as diagnostic and prognostic biomarkers. BMB Rep 2012; 45(12):677-85; PMID:23261052; http://dx.doi.org/10.5483/BMBRep.2012.45.12.236
  • Pedersen JW, Gentry-Maharaj A, Nøstdal A, Fourkala EO, Dawnay A, Burnell M, Zaikin A, Burchell J, Papadimitriou JT, Clausen H, et al. Cancer associated auto-antibodies to MUC1 and MUC4 - A blinded case-control study of colorectal cancer in UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Int J Cancer 2014; 134(9):2180-8; PMID:24122770.
  • Wen YJ, Mancino A, Pashov A, Whitehead T, Stanley J, Kieber-Emmons T. Antigen binding of human IgG Fabs mediate ERK-associated proliferation of human breast cancer cells. DNA Cell Biol 2005; 24(2):73-84; PMID:15699628; http://dx.doi.org/10.1089/dna.2005.24.73
  • Montgomery RB, Makary E, Schiffman K, Goodell V, Disis ML. Endogenous anti-HER2 antibodies block HER2 phosphorylation and signaling through extracellular signal-regulated kinase. Cancer Res 2005; 65(2):650-6; PMID:15695410
  • DuPage M, Mazumdar C, Schmidt LM, Cheung AF, Jacks T. Expression of tumour-specific antigens underlies cancer immunoediting. Nature 2012; 482(7385):405-9; PMID:22318517; http://dx.doi.org/10.1038/nature10803
  • Watanabe T, Wu TT, Catalano PJ, Ueki T, Satriano R, Haller DG, Benson AB 3rd, Hamilton SR. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 2001; 344(16):1196-206; PMID:11309634; http://dx.doi.org/10.1056/NEJM200104193441603
  • Somers VA, Brandwijk RJ, Joosten B, Moerkerk PT, Arends JW, Menheere P, Pieterse WO, Claessen A, Scheper RJ, Hoogenboom HR, et al. A panel of candidate tumor antigens in colorectal cancer revealed by the serological selection of a phage displayed cDNA expression library. J Immunol 2002; 169(5):2772-80; PMID:12193752; http://dx.doi.org/10.4049/jimmunol.169.5.2772
  • Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 2009; 9(6):400-14; PMID:19440234; http://dx.doi.org/10.1038/nrc2657
  • Hansen S, Hupp TR, Lane DP. Allosteric regulation of the thermostability and DNA binding activity of human p53 by specific interacting proteins. CRC Cell Transformation Group. J Biol Chem 1996; 271(7):3917-24; PMID:8632013
  • Ruiz PJ, Wolkowicz R, Waisman A, Hirschberg DL, Carmi P, Erez N, Garren H, Herkel J, Karpuj M, Steinman L, et al. Idiotypic immunization induces immunity to mutated p53 and tumor rejection. Nat Med 1998; 4(6):710-2; PMID:9623981; http://dx.doi.org/10.1038/nm0698-710
  • Koebel CM, Vermi W, Swann JB, Zerafa N, Rodig SJ, Old LJ, Smyth MJ, Schreiber RD. Adaptive immunity maintains occult cancer in an equilibrium state. Nature 2007; 450(7171):903-7; PMID:18026089; http://dx.doi.org/10.1038/nature06309
  • Vesely MD, Schreiber RD. Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy. Ann N Y Acad Sci 2013; 1284:1-5; PMID: 23651186; http://dx.doi.org/10.1111/nyas.12105
  • Coomber DW, Hawkins NJ, Clark MA, Ward RL. Generation of anti-p53 Fab fragments from individuals with colorectal cancer using phage display. J Immunol 1999; 163(4):2276-83; PMID:10438972
  • Rader C. Generation of human Fab libraries for phage display. Methods Mol Biol 2012; 901:53-79; PMID:22723094; http://dx.doi.org/10.1007/978-1-61779-931-0_4

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.